"We have since added Tru-D to our enhanced cleaning strategies as an important line of defense in protecting our patients and staff.”
Memphis, TN (PRWEB) June 02, 2016
During a recent presentation at the Society for Healthcare Epidemiology of America (SHEA) Spring Conference, leading researcher Deverick Anderson, MD discussed the effectiveness of UV disinfection on reducing facility-wide, hospital-acquired infection rates. During the seminar, Anderson confirmed that UV disinfection effectively kills bacteria and keeps microorganisms from replicating. Further, he explained that when UV is used hospital-wide to disinfect isolation discharge cases, HAI scores drop for the entire facility.
“Tru-D’s efficacy and role in reducing HAIs continues to be proven by leading researchers and independent, third-party validations,” said Chuck Dunn, president and CEO of Tru-D SmartUVC. “We are eager for the first-ever, randomized, clinical trial on UV disinfection, the Benefits of Enhanced Terminal Room Disinfection study, to be released. This trial ultimately proved Tru-D’s ability to affect HAI rates throughout entire healthcare facilities.”
Due to its patented Sensor360 technology that removes any chance of human error in the disinfection process, Tru-D was the only UV robot of its kind chosen for the first randomized, clinical trial on UV disinfection. The Benefits of Enhanced Terminal Room Disinfection (BETR-D) study, which was funded by the Centers for Disease Control and Prevention, proved that enhanced terminal room cleaning strategies decreased the cumulative incidences of multidrug-resistant organisms, and the largest decreases were seen when Tru-D was added to the standard cleaning protocols. During his presentation, Anderson noted that one of the additional analyses for the clinical trial was not to focus solely on the next patient in the room but to expand the analysis to all patients in the hospital. In doing so, significant, hospital-wide HAI reductions were observed with cumulative incidences of MRSA, VRE and C. diff decreasing by statistical significant amounts. This indicates that targeting highest risk rooms with enhanced disinfection practices make hospitals safer overall, improving outcomes for every patient who walks through its doors. Final results are undergoing peer-review and are expected to be published in the near future.
“The BETR-D study was a well-controlled, 28-month, intensive clinical trial that involved nine hospitals and more than 600,000 patient days,” said Ron Halleen, Director of Environmental Services at Alamance Regional Hospital, one of the BETR-D study participating hospitals. “We have since added Tru-D to our enhanced cleaning strategies as an important line of defense in protecting our patients and staff.”
Tru-D is an automated, remotely-operated UV disinfection system that self-adjusts to the size and content dynamics of any room to deliver a continuous, lethal dose of UVC light energy necessary for complete, total room disinfection. It works by generating and measuring UVC light to deliver a consistent dosage, which is proven to modify the DNA structure of infectious bacteria and spores such as C. diff, MRSA and VRE, and eliminate the risk of transmitting infections through contaminated surfaces. As energy is reflected around the room, shadowed areas are reached and pathogens are eradicated ensuring a thorough disinfection outcome, every time.
For more information and links to independent studies, visit Tru-D.com.